INSMED INC - NOTE 1.750% 1/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q3 2024

Type / Class
Debt / NOTE 1.750% 1/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INSMED INC - NOTE 1.750% 1/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q3 $0 $0 -$386,225,881 0
2024 Q2 $228,506,000 $386,764,432 +$53,699,119 171.1% 17
2024 Q1 $224,282,000 $239,051,647 +$16,104 106.0% 17
2023 Q4 $224,248,000 $238,267,769 +$2,493,781 106.13% 19
2023 Q3 $222,911,000 $220,529,516 +$351,605 98.83% 24
2023 Q2 $222,881,000 $211,853,549 +$40,881 95.1% 27
2023 Q1 $222,855,000 $203,294,214 +$224,019 91.15% 27
2022 Q4 $182,533,500 $170,423,345 -$22,724,053 93.25% 27
2022 Q3 $218,857,000 $209,498,067 -$3,057,543 97.18% 29
2022 Q2 $178,843,500 $168,353,096 -$33,191,443 93.52% 34
2022 Q1 $212,825,500 $212,389,478 +$4,934,944 99.81% 34
2021 Q4 $207,792,500 $212,716,792 -$1,918,831 102.68% 38
2021 Q3 $209,871,300 $217,009,825 -$4,170,428 103.45% 37
2021 Q2 $212,977,300 $223,731,478 -$225,420,464 104.97% 37
2021 Q1 $430,019,999 $480,796,963 -$16,411,664 111.68% 46
2020 Q4 $445,277,000 $503,255,288 +$5,959,333 112.72% 45
2020 Q3 $445,076,000 $484,570,341 +$20,993,057 108.94% 41
2020 Q2 $428,775,790 $420,728,679 +$28,118,770 97.48% 43
2020 Q1 $414,366,175 $348,619,724 +$17,491,640 83.98% 43
2019 Q4 $390,638,800 $377,078,368 +$31,211,173 96.58% 45
2019 Q3 $366,408,000 $306,948,239 +$6,575,470 83.68% 41
2019 Q2 $348,023,811 $357,737,182 -$47,180,623 97.32% 40
2019 Q1 $393,755,000 $395,206,116 +$28,295,214 100.94% 42
2018 Q4 $387,712,000 $275,728,750 +$8,539,545 71.22% 46
2018 Q3 $377,052,073 $319,663,900 -$13,525,183 84.56% 43
2018 Q2 $388,814,450 $357,425,933 +$22,938,247 91.81% 42
2018 Q1 $369,362,961 $329,125,036 +$329,125,036 88.84% 51